Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Colorcon
AstraZeneca
Cerilliant
Teva
Dow
Chubb
Johnson and Johnson

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 061633

« Back to Dashboard

NDA 061633 describes ROBIMYCIN, which is a drug marketed by Robins Ah and is included in one NDA. Additional details are available on the ROBIMYCIN profile page.

The generic ingredient in ROBIMYCIN is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 061633
Tradename:ROBIMYCIN
Applicant:Robins Ah
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 061633

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, DELAYED RELEASE;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Army
Cantor Fitzgerald
Chubb
Federal Trade Commission
McKesson
Baxter
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.